SIRPA and neoplasm: CD47- SIRPα interaction leads to recruitment of downstream Src homology-2 domain-containing protein tyrosine phosphatases (SHP-1 and SHP-2), preventing the accumulation of myosin-IIA at the phagocytic synapse, thereby inhibiting macrophage-mediated tumor phagocytosis [62].